Rapid Antigen Test Combine with Nucleic Acid Detection: A Better Strategy for COVID-19 Screening at Points of Entry
暂无分享，去创建一个
Z. J. Cheng | Z. Zhan | Jie Li
[1] Chih-Kai Chang,et al. SARS-CoV-2 variants with T135I nucleocapsid mutations may affect antigen test performance , 2021, International Journal of Infectious Diseases.
[2] Jonghoo Lee,et al. Comparing the diagnostic accuracy of rapid antigen detection tests to real time polymerase chain reaction in the diagnosis of SARS-CoV-2 infection: A systematic review and meta-analysis , 2021, Journal of Clinical Virology.
[3] S. Reardon. How the Delta variant achieves its ultrafast spread. , 2021, Nature.
[4] D. McManus,et al. Longitudinal assessment of diagnostic test performance over the course of acute SARS-CoV-2 infection. , 2021, The Journal of infectious diseases.
[5] K. Harmon,et al. A SARS-CoV-2 Nucleocapsid Variant that Affects Antigen Test Performance , 2021, Journal of Clinical Virology.
[6] F. Cerutti,et al. Urgent need of rapid tests for SARS CoV-2 antigen detection: Evaluation of the SD-Biosensor antigen test for SARS-CoV-2 , 2020, Journal of Clinical Virology.
[7] M. Capobianchi,et al. Performance of a novel diagnostic assay for rapid SARS-CoV-2 antigen detection in nasopharynx samples , 2020, Clinical Microbiology and Infection.
[8] S. Dittrich,et al. Evaluation of a novel antigen-based rapid detection test for the diagnosis of SARS-CoV-2 in respiratory samples , 2020, International Journal of Infectious Diseases.